Concepedia

Tomonari Yamashita

TY

Statistics

Publications

5

Citations

170

H-Index

5

Active since

2006

Affiliations

Daiichi-Sankyo (Japan)(Current)

Saitama Medical University

Tokyo National Hospital

National Cancer Center Hospital East

Tomonari Yamashita is an author at Daiichi-Sankyo (Japan) specializing in pharmacotherapy, medicine, and pharmacology.

Top concepts

Publications per year

2006–2022

5

Publications

5

Safety and pharmacokinetics of milademetan, a MDM2 inhibitor, in Japanese patients with solid tumors: A phase I study

Shunji Takahashi, Yutaka Fujiwara, Kenji Nakano et al. · Cancer Science · 2021 · 71 citations · Full text

Local regulation of skin blood flow during cooling involving presynaptic P2 purinoceptors in rats

Tadachika Koganezawa, Tomohisa Ishikawa, Yukiyoshi Fujita et al. · British Journal of Pharmacology · 2006 · 36 citations · Full text

, , +21

Patritumab plus trastuzumab and paclitaxel in human epidermal growth factor receptor 2‐overexpressing metastatic breast cancer

Hirofumi Mukai, Toshiaki Saeki, Kenjiro Aogi et al. · Cancer Science · 2016 · 36 citations · Full text

First-in-Human Study of the EZH1/2 Dual Inhibitor Valemetostat in Relapsed or Refractory Non-Hodgkin Lymphoma (NHL) - Updated Results Focusing on Adult T-Cell Leukemia-Lymphoma (ATL)

Satoko Morishima, Kenji Ishitsuka, Koji Izutsu et al. · Blood · 2019 · 16 citations

Phase I dose-escalation study of milademetan in patients with relapsed or refractory acute myeloid leukemia

Naohiro Sekiguchi, Senji Kasahara, Toshihiro Miyamoto et al. · International Journal of Hematology · 2022 · 11 citations · Full text

, , +10

1–5 of 5